Clinical trial
Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)
NCT00007189 is registered in ClinicalTrials.gov with Seattle Institute for Biomedical and Clinical Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)
- Lead sponsor
- Seattle Institute for Biomedical and Clinical Research
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2001
- Completion date
- Not reported
- Enrollment
- 2,625
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.